Status:
UNKNOWN
Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale
Lead Sponsor:
University Hospital, Geneva
Conditions:
Stroke
Foramen Ovale, Patent
Eligibility:
All Genders
18-90 years
Brief Summary
Following a cryptogenic stroke, many patients are nowadays treated with the percutaneous closure of a patent foramen ovale (PFO), assuming that the aetiology of the stroke is secondary to a paradoxica...
Detailed Description
At follow-up the following exams will be performed: * at hospital discharge: chest X-ray +/- TTE + 7-days event loop record (ELR) * at 6 months: clinical cardiologic and neurologic examination + TTE ...
Eligibility Criteria
Inclusion
- 18 years old patients
- signed informed consent
- all consecutive patients undergoing a successful percutaneous closure of a PFO secondary to a cryptogenic stroke
Exclusion
- all patients with an alternative aetiology of the initial stroke
- all patients in whom the percutaneous closure of the PFO is contraindicated
- all patients with a known allergy to aspirin and or clopidogrel
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01149447
Start Date
January 1 2001
Last Update
August 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Geneva
Geneva, Canton of Geneva, Switzerland, 1211